Bellevue Asset Management (Switzerland)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$8.43M	Buy	60,000 +4,000	+7%	+$554K	1.29%	26
2015 Q3	$7.44M	Hold	56,000	–	–	1.21%	27
2015 Q2	$9.86M	Sell	56,000 -2,500	-4%	-$449K	1.37%	23
2015 Q1	$10.1M	Buy	+58,500	New	+$10M	1.41%	20

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Herndon Capital Management Atlanta, Georgia $659M AUM 22.02% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s JAZZ Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) increased its Jazz Pharmaceuticals (JAZZ) stake by 7.1% in Q4 2015, buying an estimated $554K and bringing the position to 60,000 shares worth $8.43M. The position accounts for 1.29% of the portfolio, ranked #26.

Bellevue Asset Management (Switzerland) first reported a position in JAZZ in Q1 2015 and has held it in 4 quarters since. The position peaked at $10.1M in Q1 2015. 346 funds tracked by Wall St. Rank hold JAZZ as of Q4 2015.

Bellevue Asset Management (Switzerland) held 60,000 shares of Jazz Pharmaceuticals worth $8.43M as of Q4 2015.
Bellevue Asset Management (Switzerland) bought 4,000 Jazz Pharmaceuticals shares in Q4 2015, an estimated $554K.
Jazz Pharmaceuticals made up 1.29% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #26 holding.
Bellevue Asset Management (Switzerland) first reported a position in Jazz Pharmaceuticals in Q1 2015 and has held it in 4 quarters since.
Bellevue Asset Management (Switzerland)'s Jazz Pharmaceuticals position peaked at $10.1M in Q1 2015.
346 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.